Project Grant R21AI190740
Award Date
5/16/25
Completion Date
4/30/27
Dollars Obligated
$254K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award of $637,275 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to uncover the adaptation mechanisms responsible for stress-induced antibiotic tolerance in major pathogenic bacterial species. The research, conducted by the Texas A&M Engineering Experiment Station (Tees), aims to understand how Gram-negative bacterial cells rapidly restrict...
This $569,210 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to structurally and functionally characterize three key proteins responsible for antimicrobial peptide/colistin resistance in Gram-negative bacteria, including high-threat pathogens like carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae. The research aims to develop...
This $2,308,174 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to develop new antibiotic combinations and dosing strategies to combat carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae. The award, which runs from August 8, 2024 to May 31, 2029, involves three projects and three cores conducted by the University of Florida, the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,379,734 to the University of Texas at Austin to conduct research on microcin antibacterial proteins. The goal is to better understand how these small proteins can overcome the outer membrane permeability barrier of Gram-negative bacteria, a major challenge in developing new antibiotics. The research aims to link...
This federal Project Grant award, totaling $195,625.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to structurally and functionally characterize phosphoethanolamine (PEtN) transferases, which are enzymes responsible for conferring resistance to cationic antimicrobial peptides and polymyxin antibiotics in certain Gram-negative bacteria. The research aims...
The federal Project Grant award K99AI180984, issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support a research project focused on studying the functions and evolutionary roles of rapidly-evolving proteins in bacterial pathogenicity. The $209,952 grant awarded to the University of Texas Southwestern Medical Center, a component of the University of Texas System, aims to develop advanced...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $749,417 to President and Fellows of Harvard College to conduct research focused on developing novel antibiotics to address the challenge of multi-drug resistant bacterial pathogens. The research aims to synthesize and evaluate new antibiotic compounds that target the lipoprotein transport pathway in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $383,750 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Nebraska Medical Center (UNMC) to discover novel antimicrobial peptides that can effectively eliminate drug-resistant gram-negative bacteria. The project aims to elucidate the structure-activity relationship, toxicity, pharmacokinetics, and in vivo efficacy of a novel antimicrobial peptide called Verine...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Rowan University a $474,363 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop novel, daptomycin-inspired antimicrobial peptides using non-canonical amino acids. The goal is to create peptide molecules that replicate the key antimicrobial mechanisms of daptomycin, such as calcium binding and lipid membrane disruption, while improving resistance to degradation and enhancing the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $259,461 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Methodist Hospital Research Institute (HMRI) in Houston, Texas to investigate the mechanisms of antibiotic resistance and clinical outcomes of non-carbapenemase producing carbapenem-resistant Klebsiella pneumoniae (NCP-KPN) infections. The research project aims to characterize the genomic factors associated with discordant carbapenem...